47
Halia Therapeutics, Inc. raises $3.5M under Reg D
Company raise · Raising · Offering $20M · Sold $3.5M · LEHI, UT · filed 2026-08-31
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Jim B. Savas | Director |
| David Bearss | Executive Officer, Director |
| Jeffrey Burton | Executive Officer |
| Gary B. Sabin | Director |
| Todd S.K. Pedersen | Director |
| Jared Bearss | Director |
| John S.K. Kauwe | Director |
Signed by Jeffrey Burton, Chief Financial Officer.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.